Two homologous phosphatases, Sts-1 and Sts-2, have been established as negative regulators of signaling pathways within cells of the mammalian immune system. The Sts proteins are characterized by a distinct tripartite structure consisting of two protein-interaction domains and a C-terminal 2H-phosphatase domain (StsHP). They are structurally and enzymatically very distinct from other intra-cellular phosphatases that regulate immune signaling pathway. Recently, Sts-/- mice were evaluated for susceptibility to infection by Francisella tularensis, a gram-negative bacterial pathogen that is the causative agent of tularemia. F. tularensis is of such high virulence that it is classified as a Tier 1 Select Agent by the United States government, along with other potential agents of bioterrorism. Following supra-lethal infectious doses of F. tularensis, Sts-/- mice displayed profound resistance and prolonged survival. The Sts phenotype was associated with an altered inflammatory response in peripheral tissues and enhanced pathogen clearance. Studying the role of the Sts proteins in the anti-bacterial immune response is expected to identify new opportunities to optimize host immune responses toward a deadly human pathogen. Our long-term goal is to develop strategies that promote effective anti-microbial immune responses without accompanying deleterious immuno-pathology. We hypothesize that the Sts phosphatases regulate inflammatory signaling pathways that control mononuclear phagocyte responses to severe bacterial infections, such that their functional inactivation results in a distinct inflammatory environment that favors enhanced clearance. The objective of this study is to establish the role of the Sts proteins in regulating the cellular and molecular anti-bacterial immune response. We plan to test our hypothesis and accomplish our overall objective by completing the following Specific Aim:
Specific Aim 1 : Define the role of the Sts proteins in regulating monocyte inflammatory responses to systemic Francisella infection.
Specific Aim 2 : Define the role of the Sts proteins in regulating the microbicidal responses of marrow-derived monocytes. This proposal is innovative because it will reveal a novel regulatory mechanism controlling the immune response to a deadly bacterial pathogen. The proposed studies are significant because their completion will promote the development of novel immune-enhancing therapeutic strategies to improve clinical outcomes for the treatment of lethal microbial infections. Thus, long-term success of this work has the potential to significantly reduce the morbidity and mortality attributed to many bacterial pathogens.

Public Health Relevance

Francisella tularensis is a highly virulent and contagious gram-negative bacterium that replicates to high titer within the cytosol of a number of cell types. In a murine model of systemic tularemia, mice lacking the immuno-modulatory Sts-1 and -2 phosphatases are significantly protected from disease. Deciphering the role of the Sts proteins in mediating resistance to F. tularensis provides an opportunity to develop more effective immune enhancing anti-microbial therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI133381-01A1
Application #
9529951
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mallia, Conrad M
Project Start
2018-01-01
Project End
2019-12-31
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Genetics
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794